Skip to main content
. 2015 Oct 26;10(10):e0140584. doi: 10.1371/journal.pone.0140584

Table 1. Participant characteristics.

Variable Resistance (n = 17) Balance (n = 15) p-value a
Age (yr) 75.7 ± 5.5 75.7 ± 7.2 0.882
No. of female subjects 5 (29.4%) 6 (40%) 0.529 b
Duration of Disease (yr) 10.1 ± 6.0 9.3 ± 7.9 0.455
BMI (kg/m2) 27.9 ± 5.5 25.5 ± 4.4 0.142
H&Y 2.8 ± 0.26 2.7 ± 0.4 0.216
H&Y (Range) 2.5–3.0 2.5–3.0 n/a
UPDRS total (ON) 40.2 ± 12.5 37.7 ± 13.1 0.455
UPDRS part II (ON) 13.4 ± 5.1 11.1 ± 6.0 0.105
UPDRS part III (ON) 23.6 ± 9.5 22.3 ± 6.1 0.941
FAB scale 22.2 ± 4.8 24.5 ± 4.6 0.123
MMSE 27.3 ± 3.6 27.7 ± 3.0 0.891
MMSE (Range) 17–30 20–30 n/a
PASE score 104.6 ± 87.3 77.2 ± 63.1 0.576
LEDD (mg/day) 817.4 ± 468.0 674.7 ± 294.9 0.318

If not indicated differently, values are either mean ± SD or number and percentage. BMI, Body-Mass-Index; FAB, Fullerton Advanced Balance; H&Y, Hoehn & Yahr; LEDD, levodopa equivalent daily dose; MMSE, Mini-Mental State Examination; PASE, Physical Activity Scale for the Elderly; UPDRS, Unified Parkinson’s Disease Rating Scale

a unless otherwise indicated P-value of independent samples Mann-Whitney-U-Test

b P-value of Chi-Square Test.